Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Allergol Immunopathol (Madr) ; 48(2): 149-157, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31477403

RESUMO

OBJECTIVES: ß-lactoglobulin (ß-Lg)-sensitized mice model was employed to investigate the correlation between Lactobacillus acidophilus KLDS 1.0738 (Lap KLDS 1.0738) modulating gut microbiota and inducting Toll-like receptors (TLRs) expression. METHODS: The alterations of mice fecal microbiota were analyzed by 16S rRNA gene sequencing. The serum cytokines production and TLR4/NF-κB mRNA expression in the colon tissues were measured by ELISA kit and quantitative RT-PCR, respectively. RESULTS: The results showed that Lap KLDS 1.0738 pretreatment attenuated ß-Lg-induced hypersensitivity, accompanied with a diminished expression of TLR4/NF-κB signaling. Moreover, oral administration of Lap KLDS 1.0738 improved the richness and diversity of fecal microbiota, which was characterized by fewer Proteobacteria phylum and Helicobacteraceae family, and higher Firmicutes phylum and Lachnospiraceae family than allergic group. Notably, TLR4/NF-κB expression was positively correlated with the family of Helicobacteraceae in allergic group, but negatively correlated with the family of Lachnospiraceae, Ruminococcaceae and anti-inflammatory cytokines level. A significant positive correlation was observed between TLR4/NF-κB expression and the production of histamine, total IgE and pro-inflammatory cytokines. CONCLUSIONS: Intake of Lap KLDS 1.0738 can influence the gut bacterial composition, which might result in recognizing TLRs signaling so as to inhibit allergic response.


Assuntos
Microbioma Gastrointestinal , Hipersensibilidade a Leite/imunologia , Hipersensibilidade a Leite/microbiologia , Probióticos/farmacologia , Receptor 4 Toll-Like/imunologia , Animais , Modelos Animais de Doenças , Feminino , Microbioma Gastrointestinal/imunologia , Lactobacillus acidophilus , Lactoglobulinas/imunologia , Lactoglobulinas/toxicidade , Camundongos , Camundongos Endogâmicos BALB C
2.
Zh Mikrobiol Epidemiol Immunobiol ; (10): 106-9, 1976 Oct.
Artigo em Russo | MEDLINE | ID: mdl-1007709

RESUMO

Antibrucellosis lactoglobulin obtained by the author had higher specific antibody titres (1 : 81920) than the gamma-globulin batches prepared earlier from the bovine blood serum (1 : 3200). The suggested antibrucellosis lactoglobulin was harmless, of low reactogenicity and produced a definite therapeutic action when administrated to the infected animals. Since lactoglobulin is less expensive than gamma-globulin further work on the improvement of technology of obtaining the former and on the elaboration of the most effective schemes of its use are of expedience.


Assuntos
Brucella/imunologia , Lactoglobulinas/imunologia , Animais , Brucelose/tratamento farmacológico , Bovinos/imunologia , Quimioterapia Combinada , Cobaias , Humanos , Injeções Intramusculares , Lactoglobulinas/uso terapêutico , Lactoglobulinas/toxicidade , Camundongos , Coelhos , Estreptomicina/uso terapêutico
3.
Artigo em Russo | MEDLINE | ID: mdl-1759523

RESUMO

A preclinical study of seven batches of lactoglobulin, a new biological preparation against opportunistic bacteria and salmonellae, has been carried out. High antibacterial activity of the preparation with respect to the virulent forms of Salmonella typhimurium, Salmonella enteritidis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus vulgaris, Proteus mirabilis has been established. The preparation has been shown to be safe and nontoxic. The 4-year term of its storage at a temperature of 6 degrees +/- 4 degrees C has been substantiated.


Assuntos
Bactérias/efeitos dos fármacos , Lactoglobulinas/farmacologia , Salmonella/efeitos dos fármacos , Animais , Armazenamento de Medicamentos , Cobaias , Klebsiella pneumoniae/efeitos dos fármacos , Lactoglobulinas/química , Lactoglobulinas/toxicidade , Camundongos , Testes de Sensibilidade Microbiana , Proteus/efeitos dos fármacos , Pseudomonas aeruginosa/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Fatores de Tempo
4.
Food Chem ; 141(3): 2305-13, 2013 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-23870962

RESUMO

The dairy protein ß-lactoglobulin (ßlg) is known to form a complex with fatty acids (FA). Due to industrial processing, ßlg is often in its non-native form in food products, which can modify the FA/ßlg complex properties. We investigated the interaction of bovine ßlg, in selected structural forms (native ßlg, a covalent dimer and as nanoparticles), with linoleate (C18:2). Using fluorescence and Isothermal Titration Calorimetry, linoleate was found to bind ßlg at two different binding sites. Regardless of the structural state of ßlg, association constants remained in the same order of magnitude. However, the stoichiometry increased up to 6-fold for nanoparticles, compared to that of native ßlg. The impact of these structural changes on linoleate uptake in vitro was measured by cytotoxicity assays on Caco-2 cells. The order of cytotoxicity of linoleate was as follows: free>complexed to dimers>complexed to nanoparticles>complexed to native ßlg. Therefore, the in vitro cytotoxicity of linoleate could be modulated by altering the state of ßlg aggregation, which in turn affects its binding capacity to the FA.


Assuntos
Lactoglobulinas/química , Ácido Linoleico/química , Animais , Sítios de Ligação , Células CACO-2 , Bovinos , Proliferação de Células/efeitos dos fármacos , Dimerização , Humanos , Concentração de Íons de Hidrogênio , Cinética , Lactoglobulinas/metabolismo , Lactoglobulinas/toxicidade , Ácido Linoleico/metabolismo , Ácido Linoleico/toxicidade , Ligação Proteica , Dobramento de Proteína
5.
Microbes Infect ; 15(6-7): 506-10, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23518265

RESUMO

Previous studies have shown that 3-hydroxyphthalic anhydride-modified bovine beta-lactoglobulin is a promising anti-HIV microbicide candidate. Here we found that this chemically modified protein, designated JB01, exhibited highly potent antiviral activity against infection by human papillomaviruses (HPV), including HPV6, HPV16 and HPV18. Its anti-HPV activity was correlated with the percentage of modified lysine and arginine residues in JB01. This modified milk protein had no cytotoxicity at the concentration of 1 mg/ml, and it is highly stable at room temperature and 37 °C for at least 12 weeks. These results suggest that JB01 has good potential to be developed as an effective, safe and inexpensive antiviral agent for treatment and prevention of HPV infection.


Assuntos
Antivirais/farmacologia , Papillomavirus Humano 16/efeitos dos fármacos , Papillomavirus Humano 18/efeitos dos fármacos , Papillomavirus Humano 6/efeitos dos fármacos , Lactoglobulinas/farmacologia , Anidridos Ftálicos/farmacologia , Animais , Antivirais/química , Antivirais/toxicidade , Bovinos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Papillomavirus Humano 16/crescimento & desenvolvimento , Papillomavirus Humano 18/crescimento & desenvolvimento , Papillomavirus Humano 6/crescimento & desenvolvimento , Humanos , Concentração Inibidora 50 , Lactoglobulinas/química , Lactoglobulinas/toxicidade , Anidridos Ftálicos/química , Anidridos Ftálicos/toxicidade , Estabilidade Proteica , Relação Estrutura-Atividade , Temperatura , Fatores de Tempo
6.
Infect Immun ; 56(10): 2552-7, 1988 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3417349

RESUMO

Actinobacillus actinomycetemcomitans is a fastidious, facultative gram-negative rod associated with endocarditis, certain forms of periodontal disease, and other focal infections. Human neutrophils have demonstrated bactericidal activity against A. actinomycetemcomitans, and much of the oxygen-dependent killing has been attributed to the myeloperoxidase-H2O2-halide system. However, the contribution of other neutrophil components to killing activity is obscure. Lactoferrin, an iron-binding glycoprotein, is a major constituent of neutrophil-specific granules and is also found in mucosal secretions. In this report, we show that human lactoferrin is bactericidal for A. actinomycetemcomitans. Killing activity required an unsaturated (iron- and anion-free) molecule that produced a 2-log decrease in viability within 120 min at 37 degrees C at a concentration of 1.9 microM. Besides exhibiting concentration dependence, killing kinetics were affected by minor variations in temperature and pH. Magnesium, a divalent cation thought to stabilize lipopolysaccharide interactions on the surface of gram-negative organisms, enhanced lactoferrin killing of A. actinomycetemcomitans, while other cations, such as potassium and calcium, had no effect. Our data suggest that lactoferrin contributes to killing of A. actinomycetemcomitans by human neutrophils and that it may also play a significant role in innate secretory defense against this potential periodontopathogen.


Assuntos
Actinobacillus/efeitos dos fármacos , Lactoferrina/toxicidade , Lactoglobulinas/toxicidade , Cátions/farmacologia , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Magnésio/farmacologia , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA